Wagner Wealth Management, LLC Amgen Inc Transaction History

Wagner Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $57,677 - $64,185	250 New	250 $61,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $54,817 - $60,642	-250 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $39,776 - $45,520	200 Added 400.0%	250 $56,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $11,095 - $12,930	50 New	50 $12,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $29,644 - $35,300	-137 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $1,852 - $2,088	10 Added 7.87%	137 $28,000
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $6,143 - $6,900	37 Added 41.11%	127 $23,000
Q4 2017 Feb 22, 2018	BUY	$168.79 - $188.59 $15,191 - $16,973	90	90 $16,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wagner Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wagner Wealth Management, LLC with notifications on news.